Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension
Open accessThe DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Background: Right ventricular (RV) function is the major determinant for both functional capacity and survival in patients with pulmonary arterial hypertension (PAH). Despite the recognized clinical importance of preserving RV function, the subcellular mechanisms that govern the transition from a compensated to a decompensated state remain poorly understood and as a consequence there are no clinically established treatments for RV failure and a paucity of clinically useful biomarkers. Accumulating evidence indicates that long noncoding RNAs are powerful regulators of cardiac development and disease. Nonetheless, their implication in adverse RV remodeling in PAH is unknown. Methods: Expression of the long noncoding RNA H19 was assessed by quantitative PCR in plasma and RV from patients categorized as control RV, compensated RV or decompensated RV based on clinical history and cardiac index. The impact of H19 suppression using GapmeR was explored in 2 rat models mimicking RV failure, namely the monocrotaline and pulmonary artery banding. Echocardiographic, hemodynamic, histological, and biochemical analyses were conducted. In vitro gain- and loss-of-function experiments were performed in rat cardiomyocytes. Results: We demonstrated that H19 is upregulated in decompensated RV from PAH patients and correlates with RV hypertrophy and fibrosis. Similar findings were observed in monocrotaline and pulmonary artery banding rats. We found that silencing H19 limits pathological RV hypertrophy, fibrosis and capillary rarefaction, thus preserving RV function in monocrotaline and pulmonary artery banding rats without affecting pulmonary vascular remodeling. This cardioprotective effect was accompanied by E2F transcription factor 1-mediated upregulation of enhancer of zeste homolog 2. In vitro, knockdown of H19 suppressed cardiomyocyte hypertrophy induced by phenylephrine, while its overexpression has the opposite effect. Finally, we demonstrated that circulating H19 levels in plasma discriminate PAH patients from controls, correlate with RV function and predict long-term survival in 2 independent idiopathic PAH cohorts. Moreover, H19 levels delineate subgroups of patients with differentiated prognosis when combined with the NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels or the risk score proposed by both REVEAL (Registry to Evaluate Early and Long-Term PAH Disease Management) and the 2015 European Pulmonary Hypertension Guidelines. Conclusions: Our findings identify H19 as a new therapeutic target to impede the development of maladaptive RV remodeling and a promising biomarker of PAH severity and prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Long Non-Coding RNA H19 Protects H9c2 Cells against Hypoxia-Induced Injury by Targeting MicroRNA-139
Gong, L., Xu, H., Guo, G., Zhang, T., Shi, J., & Chang, C. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485354 · Cited by 82
Retracted2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationMolecular Mechanisms of Long Noncoding RNAs
Wang, K. C., & Chang, H. Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.018 · Cited by 4,396
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Benza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Uno, H., Cai, T., Pencina, M. J., D'Agostino, R. B., & Wei, L. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4154 · Cited by 1,535
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911818 · Cited by 1,399 · cited 1×
“To avoid inherent biases attributable to interanimal variability and batch sampling, hemodynamic data (RV systolic pressure, CO, and RVEDP) collected by closed chest right heart catheterization and echocardiography before sacrifice were used to classify rats into the following 4 groups: (1) early cRV; (2) late cRV; (3…”
MethodHaddad, F., Doyle, R., Murphy, D. J., & Hunt, S. A. (2008) · Circulation · doi:10.1161/circulationaha.107.653584 · Cited by 1,304
Building the mammalian heart from two sources of myocardial cells
Buckingham, M., Meilhac, S., & Zaffran, S. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1710 · Cited by 1,204
Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension
Forfia, P. R., Fisher, M. R., Mathai, S. C., Housten-Harris, T., Hemnes, A. R., Borlaug, B. A., Chamera, E., Corretti, M. C., Champion, H. C., Abraham, T. P., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-547oc · Cited by 1,090
Right Heart Adaptation to Pulmonary Arterial Hypertension
Vonk-Noordegraaf, A., Haddad, F., Chin, K. M., Forfia, P. R., Kawut, S. M., Lumens, J., Naeije, R., Newman, J., Oudiz, R. J., Provencher, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.027 · Cited by 982
Self-citationRisk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Boucly, A., Weatherald, J., Savale, L., Jaïs, X., Cottin, V., Prevot, G., Picard, F., de Groote, P., Jevnikar, M., Bergot, E., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00889-2017 · Cited by 697
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Humbert, M., Sitbon, O., Yaïci, A., Montani, D., O'Callaghan, D. S., Jaïs, X., Parent, F., Savale, L., Natali, D., Günther, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00057010 · Cited by 674
Predicting Survival in Patients With Pulmonary Arterial Hypertension
Benza, R. L., Gomberg-Maitland, M., Elliott, C. G., Farber, H. W., Foreman, A. J., Frost, A. E., McGoon, M. D., Pasta, D. J., Selej, M., Burger, C. D., et al. (2019) · Chest · doi:10.1016/j.chest.2019.02.004 · Cited by 643
The imprinted H19 noncoding RNA is a primary microRNA precursor
Cai, X., & Cullen, B. R. (2007) · RNA · doi:10.1261/rna.351707 · Cited by 642
VENTRICULAR WEIGHT IN CARDIAC HYPERTROPHY
Fulton, R. M., Hutchinson, E. C., & Jones, A. M. (1952) · Heart · doi:10.1136/hrt.14.3.413 · Cited by 604
Vonk Noordegraaf, A., Chin, K. M., Haddad, F., Hassoun, P. M., Hemnes, A. R., Hopkins, S. R., Kawut, S. M., Langleben, D., Lumens, J., & Naeije, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01900-2018 · Cited by 569
Kylhammar, D., Kjellström, B., Hjalmarsson, C., Jansson, K., Nisell, M., Söderberg, S., Wikström, G., & Rådegran, G. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx257 · Cited by 540
Epidemiology and treatment of pulmonary arterial hypertension
Lau, E. M. T., Giannoulatou, E., Celermajer, D. S., & Humbert, M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.84 · Cited by 507 · cited 2×
“To avoid inherent biases attributable to interanimal variability and batch sampling, hemodynamic data (RV systolic pressure, CO, and RVEDP) collected by closed chest right heart catheterization and echocardiography before sacrifice were used to classify rats into the following 4 groups: (1) early cRV; (2) late cRV; (3…”
MethodResultNew Insights Into the Role of mTOR Signaling in the Cardiovascular System
Sciarretta, S., Forte, M., Frati, G., & Sadoshima, J. (2018) · Circulation Research · doi:10.1161/circresaha.117.311147 · Cited by 491
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
Wang, Z., Zhang, X.-J., Ji, Y.-X., Zhang, P., Deng, K.-Q., Gong, J., Ren, S., Wang, X., Chen, I., Wang, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4179 · Cited by 386
Long noncoding RNA Chast promotes cardiac remodeling
Viereck, J., Kumarswamy, R., Foinquinos, A., Xiao, K., Avramopoulos, P., Kunz, M., Dittrich, M., Maetzig, T., Zimmer, K., Remke, J., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1475 · Cited by 370
The long noncoding RNA Wisper controls cardiac fibrosis and remodeling
Micheletti, R., Plaisance, I., Abraham, B. J., Sarre, A., Ting, C.-C., Alexanian, M., Maric, D., Maison, D., Nemir, M., Young, R. A., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aai9118 · Cited by 349
Lahm, T., Douglas, I. S., Archer, S. L., Bogaard, H. J., Chesler, N. C., Haddad, F., Hemnes, A. R., Kawut, S. M., Kline, J. A., Kolb, T. M., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201806-1160st · Cited by 343
Self-citationZhou, X., Yin, C., Dang, Y., Ye, F., & Zhang, G. (2015) · Scientific Reports · doi:10.1038/srep11516 · Cited by 334
Augustine, D. X., Coates-Bradshaw, L. D., Willis, J., Harkness, A., Ring, L., Grapsa, J., Coghlan, G., Kaye, N., Oxborough, D., Robinson, S., et al. (2018) · Echo Research & Practice · doi:10.1530/erp-17-0071 · Cited by 333
Torbicki, A., Kurzyna, M., Kuca, P., Fijałkowska, A., Sikora, J., Florczyk, M., Pruszczyk, P., Burakowski, J., & Wawrzyńska, L. (2003) · Circulation · doi:10.1161/01.cir.0000084544.54513.e2 · Cited by 318
Bogaard, H. J., Natarajan, R., Mizuno, S., Abbate, A., Chang, P. J., Chau, V. Q., Hoke, N. N., Kraskauskas, D., Kasper, M., Salloum, F. N., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0335oc · Cited by 287
Delgado-Olguín, P., Huang, Y., Li, X., Christodoulou, D., Seidman, C. E., Seidman, J. G., Tarakhovsky, A., & Bruneau, B. G. (2012) · Nature Genetics · doi:10.1038/ng.1068 · Cited by 259
Calcium Signaling and Transcriptional Regulation in Cardiomyocytes
Dewenter, M., von der Lieth, A., Katus, H. A., & Backs, J. (2017) · Circulation Research · doi:10.1161/circresaha.117.310355 · Cited by 248
New insights into IGF-1 signaling in the heart
Troncoso, R., Ibarra, C., Vicencio, J. M., Jaimovich, E., & Lavandero, S. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.12.002 · Cited by 235
The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy
Liu, L., An, X., Li, Z., Song, Y., Li, L., Zuo, S., Liu, N., Yang, G., Wang, H., Cheng, X., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw078 · Cited by 235
Li, X., Wang, H., Yao, B., Xu, W., Chen, J., & Zhou, X. (2016) · Scientific Reports · doi:10.1038/srep36340 · Cited by 213
Pastori, C., Kapranov, P., Penas, C., Peschansky, V., Volmar, C.-H., Sarkaria, J. N., Bregy, A., Komotar, R., St. Laurent, G., Ayad, N. G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424220112 · Cited by 213
Analysis of Transcriptome Complexity Through RNA Sequencing in Normal and Failing Murine Hearts
Lee, J.-H., Gao, C., Peng, G., Greer, C., Ren, S., Wang, Y., & Xiao, X. (2011) · Circulation Research · doi:10.1161/circresaha.111.249433 · Cited by 209
Potus, F., Ruffenach, G., Dahou, A., Thebault, C., Breuils-Bonnet, S., Tremblay, È., Nadeau, V., Paradis, R., Graydon, C., Wong, R., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016382 · Cited by 207
Self-citationBisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension
de Man, F. S., Handoko, M. L., van Ballegoij, J. J. M., Schalij, I., Bogaards, S. J. P., Postmus, P. E., van der Velden, J., Westerhof, N., Paulus, W. J., & Vonk-Noordegraaf, A. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.964494 · Cited by 204
Long noncoding RNA dysregulation in ischemic heart failure
Greco, S., Zaccagnini, G., Perfetti, A., Fuschi, P., Valaperta, R., Voellenkle, C., Castelvecchio, S., Gaetano, C., Finato, N., Beltrami, A. P., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0926-5 · Cited by 202
Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer
Zhang, K., Luo, Z., Zhang, Y., Zhang, L., Wu, L., Liu, L., Yang, J., Song, X., & Liu, J. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160630 · Cited by 199
Zhang, Z., Gao, W., Long, Q.-Q., Zhang, J., Li, Y.-F., liu, D.-C., Yan, J.-J., Yang, Z.-J., & Wang, L.-S. (2017) · Scientific Reports · doi:10.1038/s41598-017-07611-z · Cited by 193
Salt, I. P., & Hardie, D. G. (2017) · Circulation Research · doi:10.1161/circresaha.117.309633 · Cited by 187
Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension
Meloche, J., Potus, F., Vaillancourt, M., Bourgeois, A., Johnson, I., Deschamps, L., Chabot, S., Ruffenach, G., Henry, S., Breuils-Bonnet, S., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.307004 · Cited by 183
Self-citationNatriuretic Peptides in the Regulation of Cardiovascular Physiology and Metabolic Events
Kerkelä, R., Ulvila, J., & Magga, J. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002423 · Cited by 170
Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure
Greco, C. M., & Condorelli, G. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.71 · Cited by 163
van der Feen, D. E., Kurakula, K., Tremblay, È., Boucherat, O., Bossers, G. P. L., Szulcek, R., Bourgeois, A., Lampron, M.-C., Habbout, K., Martineau, S., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201812-2275oc · Cited by 162
Self-citationMauritz, G.-J., Kind, T., Marcus, J. T., Bogaard, H. J., van de Veerdonk, M. C., Postmus, P. E., Boonstra, A., Westerhof, N., & Noordegraaf, A. V. (2011) · CHEST Journal · doi:10.1378/chest.10-3277 · Cited by 150
Provencher, S., Archer, S. L., Ramirez, F. D., Hibbert, B., Paulin, R., Boucherat, O., Lacasse, Y., & Bonnet, S. (2018) · Circulation Research · doi:10.1161/circresaha.117.312579 · Cited by 141
Self-citationLee, S.-R., Roh, Y.-G., Kim, S., Lee, J., Seol, S., Lee, H.-H., Kim, W.-T., Kim, W., Heo, J., Cha, H., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2680 · Cited by 141
Benza, R. L., Miller, D. P., Foreman, A. J., Frost, A. E., Badesch, D. B., Benton, W. W., & McGoon, M. D. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.09.016 · Cited by 136
Tofovic, S. P. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181f9ea8d · Cited by 115
HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension
Boucherat, O., Chabot, S., Paulin, R., Trinh, I., Bourgeois, A., Potus, F., Lampron, M.-C., Lambert, C., Breuils‐Bonnet, S., Nadeau, V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04874-4 · Cited by 113
Self-citationMitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension
Boucherat, O., Peterlini, T., Bourgeois, A., Nadeau, V., Breuils‐Bonnet, S., Boilet-Molez, S., Potus, F., Meloche, J., Chabot, S., Lambert, C., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201708-1751oc · Cited by 106
Self-citationH19 controls reactivation of the imprinted gene network during muscle regeneration
Martinet, C., Monnier, P., Louault, Y., Bénard, M., Gabory, A., & Dandolo, L. (2016) · Development · doi:10.1242/dev.131771 · Cited by 101
Kikuchi, N., Satoh, K., Kurosawa, R., Yaoita, N., Al-Mamun, M. E., Siddique, M. A. H., Omura, J., Satoh, T., Nogi, M., Sunamura, S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033113 · Cited by 100
Self-citationHuang, Z., Tian, L.-H., Yang, B., & Guo, R. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.3799 · Cited by 99
Tian, L., Potus, F., Wu, D., Dasgupta, A., Chen, K., Mewburn, J. D., Lima, P., & Archer, S. L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00828 · Cited by 88
Self-citationFOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension
Bourgeois, A., Lambert, C., Habbout, K., Ranchoux, B., Paquet-Marceau, S., Trinh, I., Breuils‐Bonnet, S., Paradis, R., Nadeau, V., Paulin, R., et al. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1619-0 · Cited by 84
Self-citationHypoxia-induced H19/YB-1 cascade modulates cardiac remodeling after infarction
Choong, O. K., Chen, C.-Y., Zhang, J., Lin, J.-H., Lin, P.-J., Ruan, S., Kamp, T. J., & Hsieh, P. C. H. (2019) · Theranostics · doi:10.7150/thno.35218 · Cited by 81
Self-citationWang, X., Li, X.-M., Song, N., Zhai, H., Gao, X., & Yang, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109208 · Cited by 75
Prognostic value of right ventricular ejection fraction in pulmonary arterial hypertension
Courand, P., Pina-Jomir, G., Khouatra, C., Scheiber, C., Turquier, S., Glérant, J., Mastroïanni, B., Gentil, B., Blanchet-Legens, A.-S., Dib, A., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00158014 · Cited by 72
The long non-coding RNA H19 promotes cardiomyocyte apoptosis in dilated cardiomyopathy
Zhang, Y., Zhang, M., Xu, W., Chen, J., & Zhou, X. (2017) · Oncotarget · doi:10.18632/oncotarget.15544 · Cited by 70
TRPC3-Nox2 complex mediates doxorubicin-induced myocardial atrophy
Shimauchi, T., Numaga‐Tomita, T., Ito, T., Nishimura, A., Matsukane, R., Oda, S., Hoka, S., Ide, T., Koitabashi, N., Uchida, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93358 · Cited by 68
Self-citationDiagnostic and prognostic value of circulating lncRNA H19 in gastric cancer
Y�r�ker, E., Keskin, M., Kulle, C. B., Holdenrieder, S., & Deligezer, U. (2018) · Biomedical Reports · doi:10.3892/br.2018.1116 · Cited by 63
Yu, J., Yang, Y., Xu, Z., Lan, C., Chen, C., Li, C., Chen, Z., Cheng, Y., Xia, X., Liao, Q., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006525 · Cited by 55
Tang, Y., He, R., An, J., Deng, P., Huang, L., & Yang, W. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.028 · Cited by 51
Right Ventricular Long Noncoding RNA Expression in Human Heart Failure
Salvo, T. G. D., Guo, Y. P., Su, Y. R., Clark, T. A., Brittain, E. L., Absi, T., Maltais, S., & Hemnes, A. R. (2015) · Pulmonary Circulation · doi:10.1086/679721 · Cited by 49
Serum level of long noncoding RNA H19 as a diagnostic biomarker of multiple myeloma
Pan, Y., Chen, H., Shen, X., Wang, X., Ju, S., Lu, M., & Cong, H. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.02.019 · Cited by 45
Luo, J., Li, Q., Pan, J., Li, L., Fang, L., & Zhang, Y. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_733_17 · Cited by 36
Cited by
Non-coding RNAs in disease: from mechanisms to therapeutics
Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-023-00662-1 · Cited by 885
Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials
Shi, Y., Zhang, H., Huang, S., Yin, L., Wang, F., Luo, P., & Huang, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01055-2 · Cited by 362
Pathology and pathobiology of pulmonary hypertension: current insights and future directions
Guignabert, C., Aman, J., Bonnet, S., Dorfmüller, P., Olschewski, A. J., Pullamsetti, S., Rabinovitch, M., Schermuly, R. T., Humbert, M., & Stenmark, K. R. (2024) · European Respiratory Journal · doi:10.1183/13993003.01095-2024 · Cited by 165
Self-citationBoucherat, O., Yokokawa, T., Krishna, V., Kalyana-Sundaram, S., Martineau, S., Breuils-Bonnet, S., Azhar, N., Bonilla, F., Gutstein, D., Potus, F., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00113-w · Cited by 64
Self-citationSvoboda, L. K., Ishikawa, T., & Dolinoy, D. C. (2022) · Environmental Epigenetics · doi:10.1093/eep/dvac017 · Cited by 27
“Prenatal phthalate exposure has also been associated with sex-specific dysregulation of DNA methylation and expression of the imprinted genes H19 and IGF2 [227], both of which have important roles in cardiovascular disease and development [228, 229].”
Background
Metadata
- Authors
- Omura, J., Habbout, K., Shimauchi, T., Wu, W.-H., Breuils-Bonnet, S., Tremblay, E., Martineau, S., Nadeau, V., Gagnon, K., Mazoyer, F., Perron, J., Potus, F., Lin, J.-H., Zafar, H., Kiely, D. G., Lawrie, A., Archer, S. L., Paulin, R., Provencher, S., Boucherat, O., & Bonnet, S.
- Venue
- Circulation
- Published
- 2020-10-13
- Volume
- 142
- Issue
- 15
- Pages
- 1464-1484
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3044802484
- Cited by
- 164
- References
- 69
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.